The most recent short interest data has been released for the 06/15/2017 settlement date, which shows a 422,370 share decrease in total short interest for Loxo Oncology, Inc (LOXO), to 3,617,366, a decrease of 10.46% since 05/31/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days (at the average volume) it would take to close out all of the open short positions if every share traded represented a short position being closed. Average daily volume for LOXO at the 06/15/2017 settlement increased to 1,245,395, as compared to 172,400 at the 05/31/2017 report. That brought "days to cover" down to 2.90, a 87.60% decrease from the 23.43 days to cover calculated at the previous short interest data release.The below chart shows the historical "days to cover" for LOXO at previous short interest release dates: A decreased "days to cover" value could indicate that short sellers are no longer expecting the same decline in stock price they once were, or it could also indicate a long bet elsewhere was closed where LOXO had been shorted as a hedge. The chart below shows the one year performance of LOXO shares, versus its 200 day moving average. Looking at this chart, LOXO's low point in its 52 week range is $17.14 per share, with $83.12 as the 52 week high point — that compares with a last trade of $81.11. According to the ETF Finder at ETF Channel, LOXO makes up 1.21% of the PowerShares DWA Healthcare Momentum Portfolio ETF (PTH) which is up by about 0.2% on the day Tuesday.
More from Stocks
Cadence Design Systems Expected to Earn 51 Cents a Share
Cadence Design Systems revenue expected to rise 8.2% to $576.1 million.
Drug Distributors Fall in After-Hours Trading on Failed Opioid Settlement Talks
Trial set to begin Monday in Cleveland in cases of state and local governments against companies that made and distributed oipiods.
Cedar Fair Stockholders Enjoy Riding the 'Golden Cross'
Shares of the amusement park operator still look bullish. Here's how to trade it.